Health Outcomes in Blood Donors and Recipients
Health Outcomes in Blood Donors and Recipients
批准号:
8474822
负责人:
EDWARD L MURPHY
金额:
$17.86万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-01-05 至 2016-05-31
关键词:
AdultAgeAlveolarAreaArthritisAutoimmune DiseasesAutoimmune ProcessBiologicalBloodBlood TransfusionBlood donorBronchitisCardiovascular systemClinicalCollaborationsComplete Blood CountConsultationsDeath RateDeveloping CountriesDiagnosisDoctor of PhilosophyEnrollmentEpidemiologistFacultyFundingGenerationsGeneticGrantHealthHuman T-lymphotropic virus 1Human T-lymphotropic virus 2ImmuneIncidenceInfectionInfective cystitisInstitutesInternationalInvestigationIrrigationJointsLaboratoriesLeadLungLymphocyteMalignant - descriptorMalignant NeoplasmsMeasuresMedicineMentorsMentorshipMid-Career Clinical Scientist Award (K24)Midcareer Investigator Award in Patient-Oriented ResearchMonitorOutcomeOutcome StudyPathogenesisPeripheral Blood Mononuclear CellPersonsPhysiciansPneumoniaPopulationPostdoctoral FellowPrevalencePublic Health SchoolsQuestionnairesRecurrenceResearchResearch ActivityResearch PersonnelResearch SupportResearch TrainingRheumatologySECTM1 geneSafetyScientistSpecimenSpinal Cord DiseasesT-Cell LeukemiaTimeToxic effectTrainingTraining ActivityTransfusionTransfusion-Transmitted VirusUnited States National Institutes of HealthVenous blood samplingVisitWagesWorld Health Organizationbasecareercohortcytokinegenetic epidemiologyglobal healthgraduate studentimprovedinternational centermortalitynovelpatient oriented researchprogramsrepositoryscreeningsexvirus genetics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Dr. Murphy is a well-established, well-funded and productive researcher who has productively utilized the K24 mechanism during the first funding period to leverage his participation in patient oriented research (POR) and to devote substantial additional time to training and mentoring. He has been successful in traditional mentoring of graduate students, fellows and junior faculty towards their own career in POR. More novel, but still fully within the scope of the K24 award's intent, he has instituted a dynamic new program in POR training for transfusion medicine MD's and PhD's in developing countries that will lead to a new generation of researchers devoted to improving the safety and availability of blood transfusion on a worldwide basis. Finally, there are still competing demands for time and funded salary between research and training activities and remaining commitments to administrative duties. Although medium-long term mentorship has been successful, the international program is still young and the applicant would like more time for several promising trainees from the short course to transition to medium to long term mentorship. An additional five years of funding is requested to enable the formation of a Center of Excellence in POR training in international transfusion safety:
¿ Continue and expand his program of high quality POR, with a research concentration on the health outcomes of transfusion transmitted viruses and genetic epidemiology.
¿ Continue and increase medium- and long-term mentorship under the umbrella of the UCSF CTSI, UC Berkeley School of Public Health and the new roadmap K12 Masters and Ph.D. programs at UCSF.
¿ Expand and obtain independent funding for international training activities, in collaboration with the UCSF Institute for Global Health, and NIH Fogarty International Center training grants
¿ Further strengthen his own research team, promoting the independence of junior faculty and a joint (UCSF and BSRI) recruitment of a genetic epidemiologist to aid the laboratory's expansion into this new area of research.
期刊论文(43)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Haemostatic trends in HIV-infected individuals in Yaoundé, Cameroon: a pilot study.
喀麦隆雅温得 HIV 感染者的止血趋势:一项试点研究。
DOI:
10.1097/mbc.0000000000000066
发表时间:
2014
期刊:
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
影响因子:
--
作者:
[Tene,Larissa, Tagny,ClaudeT, Mintya-Ndoumba,Annick, Fossi,VictorN, Mbanya,Dora]
通讯作者:
Mbanya,Dora
A review of the use of blood and blood products in HIV-infected patients.
对艾滋病毒感染者血液和血液制品使用情况的回顾。
DOI:
10.4102/sajhivmed.v13i2.146
发表时间:
2012
期刊:
Southern African journal of HIV medicine
影响因子:
1.7
作者:
[vandenBerg,Karin, vanHasselt,James, Bloch,Evan, Crookes,Robert, Kelley,James, Berger,Jonathan, Ingram,Charlotte, Dippenaar,Anel, Thejpal,Rajendra, Littleton,Neil, Elliz,Tersia, Reubenson,Gary, Cotton,Mark, Hull,JenniferC, Moodley,Pamela]
通讯作者:
Moodley,Pamela
DOI:
10.1111/j.1537-2995.2010.02634.x
发表时间:
2010-07
期刊:
Transfusion
影响因子:
2.9
作者:
[Tobler LH, Bahrami SH, Kaidarova Z, Pitina L, Winkelman VK, Vanderpool SK, Guiltinan AM, Cooper S, Busch MP, Murphy EL]
通讯作者:
Murphy EL
Demographic, risk factors and motivations among blood donors with reactive serologic tests for syphilis in São Paulo, Brazil.
巴西圣保罗进行梅毒反应性血清学检测的献血者的人口统计、危险因素和动机。
DOI:
10.1111/tme.12124
发表时间:
2014
期刊:
Transfusion medicine (Oxford, England)
影响因子:
--
作者:
[Ferreira,SC, deAlmeida-Neto,C, Nishiya,AS, Oliveira,CDL, Ferreira,JE, Alencar,CS, Levi,JE, Salles,NA, MendroneJr,A, Sabino,EC]
通讯作者:
Sabino,EC
Identification of a Novel HIV-1 Circulating Recombinant Form (CRF72_BF1) in Deep Sequencing Data from Blood Donors in Southeastern Brazil.
从巴西东南部献血者的深度测序数据中鉴定出一种新型 HIV-1 循环重组形式 (CRF72_BF1)。
DOI:
10.1128/genomea.00386-14
发表时间:
2014
期刊:
Genome announcements
影响因子:
--
作者:
[Pessôa,Rodrigo, CarneiroProietti,AnnaBárbaradeFreitas, Busch,MichaelP, Sanabani,SabriS]
通讯作者:
Sanabani,SabriS
共 21 条
Research training in HIV-related transfusion medicine and hematology in South Africa
-
批准号:9977297
-
项目类别:
-
资助金额:$30.24万
-
财政年份:2017
-
负责人:EDWARD L MURPHY
-
依托单位:
Research training in HIV-related transfusion medicine and hematology in South Africa
-
批准号:10248622
-
项目类别:
-
资助金额:$7.3万
-
财政年份:2017
-
负责人:EDWARD L MURPHY
-
依托单位:
Blood Research and EnhAnced Training against HIV in South Africa (BREATH-SA)
-
批准号:10875043
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2017
-
负责人:EDWARD L MURPHY
-
依托单位:
XV International Conference on Human Retrovirology: HTLV and Related Viruses
-
批准号:8126612
-
项目类别:
-
资助金额:$0.2万
-
财政年份:2011
-
负责人:EDWARD L MURPHY
-
依托单位:
Clinical Epidemiology of HTLV-I and HTLV-II Infection
-
批准号:6704954
-
项目类别:
-
资助金额:$13.23万
-
财政年份:2004
-
负责人:EDWARD L MURPHY
-
依托单位:
Health Outcomes in Blood Donors and Recipients
-
批准号:8073046
-
项目类别:
-
资助金额:$17.86万
-
财政年份:2004
-
负责人:EDWARD L MURPHY
-
依托单位:
Health Outcomes in Blood Donors and Recipients
-
批准号:7739298
-
项目类别:
-
资助金额:$17.67万
-
财政年份:2004
-
负责人:EDWARD L MURPHY
-
依托单位:
Clinical Epidemiology of HTLV-I and HTLV-II Infection
-
批准号:7166834
-
项目类别:
-
资助金额:$13.23万
-
财政年份:2004
-
负责人:EDWARD L MURPHY
-
依托单位:
Health Outcomes in Blood Donors and Recipients
-
批准号:8270509
-
项目类别:
-
资助金额:$17.86万
-
财政年份:2004
-
负责人:EDWARD L MURPHY
-
依托单位:
Clinical Epidemiology of HTLV-I and HTLV-II Infection
-
批准号:6841613
-
项目类别:
-
资助金额:$13.23万
-
财政年份:2004
-
负责人:EDWARD L MURPHY
-
依托单位:
Clinical Epidemiology of HTLV-I and HTLV-II Infection
-
批准号:6991203
-
项目类别:
-
资助金额:$13.23万
-
财政年份:2004
-
负责人:EDWARD L MURPHY
-
依托单位:
Clinical Epidemiology of HTLV-I and HTLV-II Infection
-
批准号:7383104
-
项目类别:
-
资助金额:$13.23万
-
财政年份:2004
-
负责人:EDWARD L MURPHY
-
依托单位:
XI International Conference on Human Retrovirology: HTLV
-
批准号:7064840
-
项目类别:
-
资助金额:$1.3万
-
财政年份:2003
-
负责人:EDWARD L MURPHY
-
依托单位:
XI International Conference on Human Retrovirology: HTLV
-
批准号:6949953
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2003
-
负责人:EDWARD L MURPHY
-
依托单位:
XI International Conference on Human Retrovirology: HTLV
-
批准号:6559867
-
项目类别:
-
资助金额:$4.6万
-
财政年份:2003
-
负责人:EDWARD L MURPHY
-
依托单位:
PATHOPHYSIOLOGY OF HTLV1 AND HTLVII INFECTION
-
批准号:6184619
-
项目类别:
-
资助金额:$118.01万
-
财政年份:1999
-
负责人:EDWARD L MURPHY
-
依托单位:
PATHOPHYSIOLOGY OF HTLV1 AND HTLVII INFECTION
-
批准号:2824181
-
项目类别:
-
资助金额:$120.74万
-
财政年份:1999
-
负责人:EDWARD L MURPHY
-
依托单位:
PATHOPHYSIOLOGY OF HTLV1 AND HTLVII INFECTION
-
批准号:6616974
-
项目类别:
-
资助金额:$7.5万
-
财政年份:1999
-
负责人:EDWARD L MURPHY
-
依托单位:
Pathophysiology of HTLV-I and HTLV-II Infection
-
批准号:7341634
-
项目类别:
-
资助金额:$92.87万
-
财政年份:1999
-
负责人:EDWARD L MURPHY
-
依托单位:
Pathophysiology of HTLV-I and HTLV-II Infection
-
批准号:7015068
-
项目类别:
-
资助金额:$92.6万
-
财政年份:1999
-
负责人:EDWARD L MURPHY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: